<?xml version="1.0" encoding="UTF-8"?><?xml-stylesheet type="text/xsl" href="//www.pharmaglobenewswire.com/main-sitemap.xsl"?>
<urlset xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:image="http://www.google.com/schemas/sitemap-image/1.1" xsi:schemaLocation="http://www.sitemaps.org/schemas/sitemap/0.9 http://www.sitemaps.org/schemas/sitemap/0.9/sitemap.xsd http://www.google.com/schemas/sitemap-image/1.1 http://www.google.com/schemas/sitemap-image/1.1/sitemap-image.xsd" xmlns="http://www.sitemaps.org/schemas/sitemap/0.9">
	<url>
		<loc>https://www.pharmaglobenewswire.com/</loc>
		<lastmod>2026-09-09T06:58:38+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaglobenewswire.com/pulmonary-hypertension-associated-with-interstitial-lung-disease-ph-ild-market-outlook-2036-growth-trends-competitive-landscape-and-future-opportunities-delveinsight/</loc>
		<lastmod>2026-09-09T06:58:38+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaglobenewswire.com/cardiac-rhythm-management-devices-market-growth-trends-companies-and-future-outlook/</loc>
		<lastmod>2026-09-09T06:50:35+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaglobenewswire.com/pulmonary-hypertension-associated-with-interstitial-lung-disease-ph-ild-market-to-grow-from-usd-3-billion-at-a-cagr-of-3-9-through-2036/</loc>
		<lastmod>2026-09-09T04:16:35+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaglobenewswire.com/ewing-sarcoma-market-to-grow-at-11-7-cagr-through-2036-reveals-delveinsight/</loc>
		<lastmod>2026-09-08T07:32:01+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaglobenewswire.com/medical-suction-devices-market-growth-trends-opportunities-and-forecast-through-2030/</loc>
		<lastmod>2026-09-08T05:54:12+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaglobenewswire.com/the-global-interventional-cardiology-devices-market-size-is-projected-to-grow-at-a-cagr-of-7-09-during-the-forecast-period-from-2026-to-2034-delveinsight/</loc>
		<lastmod>2026-09-07T06:41:48+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaglobenewswire.com/mobile-clinics-market-growth-trends-opportunities-and-future-healthcare-access/</loc>
		<lastmod>2026-09-07T05:03:39+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaglobenewswire.com/helicobacter-pylori-h-pylori-infection-market-to-witness-significant-growth-through-2032-driven-by-advancements-in-diagnostics-and-emerging-therapeutic-strategies-reveals-delveinsight/</loc>
		<lastmod>2026-09-07T04:28:30+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaglobenewswire.com/metastatic-her2-positive-breast-cancer-market-set-for-transformation-through-emerging-targeted-therapies/</loc>
		<lastmod>2026-09-04T09:18:45+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaglobenewswire.com/the-global-respiratory-monitoring-devices-market-size-is-projected-to-grow-at-a-cagr-of-5-73-during-the-forecast-period-from-2024-to-2030-delveinsight/</loc>
		<lastmod>2026-09-04T06:05:20+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaglobenewswire.com/psoriasis-market-steady-growth-driven-by-advancements-in-biologic-and-oral-therapies-by-2034/</loc>
		<lastmod>2026-09-04T05:13:44+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaglobenewswire.com/menkes-disease-market-set-to-grow-through-2036-as-first-approved-therapy-establishes-standard-of-care-and-gene-therapy-advances-preclinically/</loc>
		<lastmod>2026-09-03T11:23:40+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaglobenewswire.com/gaba-inhibitor-market-poised-for-transformation-through-2034-amid-expanding-therapeutic-opportunities/</loc>
		<lastmod>2026-09-03T06:28:56+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaglobenewswire.com/gene-therapy-market-forecast-2032-rising-demand-novel-therapies-and-commercial-potential-delveinsight/</loc>
		<lastmod>2026-09-03T06:25:05+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaglobenewswire.com/treatment-resistant-depression-market-forecast-2036-rising-demand-novel-therapies-and-commercial-potential-delveinsight/</loc>
		<lastmod>2026-09-02T10:54:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaglobenewswire.com/erectile-dysfunction-market-expected-to-witness-significant-growth-by-2034-driven-by-therapeutic-innovation-and-rising-awareness-delveinsight/</loc>
		<lastmod>2026-09-02T10:34:39+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaglobenewswire.com/herpes-labialis-market-poised-for-growth-as-innovative-treatments-reshape-care/</loc>
		<lastmod>2026-09-02T04:43:01+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaglobenewswire.com/vascular-malformations-market-set-to-expand-as-targeted-pipeline-therapies-advance-through-2036-delveinsight/</loc>
		<lastmod>2026-09-01T08:28:55+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaglobenewswire.com/tumour-necrosis-factor-ligand-superfamily-member-15-inhibitor-market-set-for-growth-as-rg6631-advances-toward-late-stage-development/</loc>
		<lastmod>2026-09-01T05:12:57+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaglobenewswire.com/the-global-otoscope-market-size-is-projected-to-grow-at-a-cagr-of-3-98-during-the-forecast-period-from-2024-to-2030-delveinsight/</loc>
		<lastmod>2026-08-31T06:15:17+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaglobenewswire.com/thyroid-gland-disorder-treatment-market-rising-prevalence-rd-breakthroughs-and-expanding-therapeutic-pipeline-drive-robust-global-growth-through-2032-2/</loc>
		<lastmod>2026-08-27T09:20:17+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaglobenewswire.com/the-global-cardiac-monitoring-devices-market-size-is-projected-to-grow-at-a-cagr-of-4-35-during-the-forecast-period-from-2026-to-2034-delveinsight/</loc>
		<lastmod>2026-08-27T08:06:48+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaglobenewswire.com/antisense-oligonucleotide-therapeutics-pipeline-emerging-drugs-companies-technologies-and-market-outlook/</loc>
		<lastmod>2026-08-26T07:15:46+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaglobenewswire.com/the-global-ophthalmic-laser-devices-market-size-is-projected-to-grow-at-a-cagr-of-4-44-during-the-forecast-period-from-2024-to-2030-delveinsight/</loc>
		<lastmod>2026-08-26T06:13:43+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaglobenewswire.com/transcatheter-aortic-valve-replacement-market-to-reach-usd-7-64-billion-by-2032-driven-by-rising-aortic-stenosis-burden-and-expanding-tavr-adoption/</loc>
		<lastmod>2026-08-25T06:34:02+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaglobenewswire.com/mobile-clinics-market-expanding-access-to-healthcare-through-innovative-mobile-solutions/</loc>
		<lastmod>2026-08-25T06:19:07+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaglobenewswire.com/congenital-adrenal-hyperplasia-market-expected-to-grow-at-a-40-cagr-through-2034-delveinsight/</loc>
		<lastmod>2026-08-25T04:13:42+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaglobenewswire.com/cyclin-dependent-kinase-like-5-deficiency-disorder-market-expected-to-experience-significant-growth-and-therapeutic-evolution-by-2034-delveinsight/</loc>
		<lastmod>2026-08-24T08:02:17+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaglobenewswire.com/adult-t-cell-leukemia-lymphoma-market-rapid-increment-driven-by-innovation-delveinsight/</loc>
		<lastmod>2026-08-24T06:14:55+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaglobenewswire.com/the-global-vital-sign-monitoring-devices-market-size-is-projected-to-grow-at-a-cagr-of-7-35-during-the-forecast-period-from-2026-to-2034-delveinsight/</loc>
		<lastmod>2026-08-21T06:28:49+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaglobenewswire.com/untreated-metastatic-or-unresectable-melanoma-pipeline-shows-promising-therapeutic-advances/</loc>
		<lastmod>2026-08-21T04:40:32+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaglobenewswire.com/huntingtons-disease-market-to-witness-robust-growth-at-a-14-cagr-through-2036-amid-emergence-of-disease-modifying-gene-and-rna-based-therapies/</loc>
		<lastmod>2026-08-21T04:19:58+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaglobenewswire.com/the-global-orthopedic-trauma-devices-market-size-is-projected-to-grow-at-a-cagr-of-5-89-during-the-forecast-period-from-2025-to-2032-delveinsight/</loc>
		<lastmod>2026-08-20T06:41:55+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaglobenewswire.com/digital-twins-in-healthcare-market-set-to-witness-significant-growth-driven-by-rising-chronic-disease-burden-ai-powered-innovation-and-expanding-clinical-applications-through-2032/</loc>
		<lastmod>2026-08-20T04:28:15+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaglobenewswire.com/alk-metastatic-nsclc-market-outlook-targeted-therapies-pipeline-innovation-competitive-dynamics-and-growth-opportunities/</loc>
		<lastmod>2026-08-19T06:45:08+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaglobenewswire.com/the-global-wound-healing-devices-market-size-is-projected-to-grow-at-a-cagr-of-5-07-during-the-forecast-period-from-2025-to-2032-delveinsight/</loc>
		<lastmod>2026-08-19T06:40:06+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaglobenewswire.com/ewing-sarcoma-epidemiology-forecast-through-2036-now-available-reports-delveinsight/</loc>
		<lastmod>2026-08-19T06:06:59+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaglobenewswire.com/cholangiocarcinoma-market-expected-to-experience-significant-growth-and-market-evolution-by-2034/</loc>
		<lastmod>2026-08-18T04:52:04+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaglobenewswire.com/delveinsights-age-related-hearing-loss-market-insight-competitive-landscape-and-market-forecast-report-covers-the-study-period-2021-2030-delveinsight/</loc>
		<lastmod>2026-08-18T04:31:29+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaglobenewswire.com/cannabinoid-pipeline-advances-as-innovative-therapies-reshape-drug-development/</loc>
		<lastmod>2026-08-17T09:39:20+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaglobenewswire.com/aplastic-anemia-market-sees-approximately-2600-total-incident-cases-across-the-7mm-in-2025/</loc>
		<lastmod>2026-08-17T06:22:04+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaglobenewswire.com/the-global-fertility-monitoring-devices-market-size-is-projected-to-grow-at-a-cagr-of-7-41-during-the-forecast-period-from-2024-to-2030-delveinsight/</loc>
		<lastmod>2026-08-17T06:11:57+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaglobenewswire.com/embolic-protection-devices-market-set-to-witness-significant-growth-driven-by-rising-cardiovascular-and-neurovascular-disease-burden-technological-advancements-and-expanding-clinical-applications-th/</loc>
		<lastmod>2026-08-14T11:09:43+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaglobenewswire.com/5036-2/</loc>
		<lastmod>2026-08-14T06:23:28+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaglobenewswire.com/donohue-syndrome-market-expected-to-gain-momentum-through-2036-according-to-delveinsight/</loc>
		<lastmod>2026-08-14T05:23:44+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaglobenewswire.com/the-global-artificial-pancreas-device-market-size-is-projected-to-grow-at-a-cagr-of-16-33-during-the-forecast-period-from-2025-to-2032-delveinsight/</loc>
		<lastmod>2026-08-13T06:53:24+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaglobenewswire.com/bipolar-disorder-market-set-to-witness-significant-growth-driven-by-rising-disease-burden-novel-pipeline-advancements-and-expanding-therapeutic-options-through-2036/</loc>
		<lastmod>2026-08-13T05:15:50+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaglobenewswire.com/hepatic-encephalopathy-market-set-to-grow-through-2030-as-golexanolone-and-axa1665-advance-through-clinical-development/</loc>
		<lastmod>2026-08-13T04:42:33+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaglobenewswire.com/the-global-fetal-monitoring-devices-market-size-is-projected-to-grow-at-a-cagr-of-6-34-during-the-forecast-period-from-2026-to-2034-delveinsight/</loc>
		<lastmod>2026-08-12T05:59:01+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaglobenewswire.com/glp-1-agonists-market-set-to-expand-through-2036-as-oral-agents-and-multi-receptor-therapies-reshape-cardiometabolic-care/</loc>
		<lastmod>2026-08-12T05:26:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaglobenewswire.com/metastatic-conventional-chondrosarcoma-market-poised-for-growth-amid-rising-disease-burden-and-emerging-therapeutic-innovations/</loc>
		<lastmod>2026-08-12T04:41:15+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaglobenewswire.com/colorectal-surgical-devices-market-to-witness-significant-growth-driven-by-rising-cancer-cases-and-surgical-innovation/</loc>
		<lastmod>2026-08-11T05:45:41+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaglobenewswire.com/the-global-atherectomy-devices-market-size-is-projected-to-grow-at-a-cagr-of-8-5-during-the-forecast-period-from-2026-to-2034-delveinsight/</loc>
		<lastmod>2026-08-11T05:34:58+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaglobenewswire.com/global-smart-medical-devices-market-size-to-reach-usd-131-33-billion-by-2032-expanding-at-a-cagr-of-12-20/</loc>
		<lastmod>2026-08-11T05:00:36+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaglobenewswire.com/rotator-cuff-injuries-market-to-witness-significant-growth-driven-by-advanced-repair-technologies-and-rising-treatment-demand/</loc>
		<lastmod>2026-08-10T11:45:03+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaglobenewswire.com/the-global-spinal-fusion-devices-market-size-is-projected-to-grow-at-a-cagr-of-5-31-during-the-forecast-period-from-2025-to-2032-delveinsight/</loc>
		<lastmod>2026-08-10T06:18:43+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaglobenewswire.com/follicular-lymphoma-market-set-to-grow-at-6-8-cagr-through-2036-amid-expanding-pipeline-therapies/</loc>
		<lastmod>2026-08-07T12:01:38+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaglobenewswire.com/fallopian-tube-cancer-market-set-to-witness-significant-growth-driven-by-rising-disease-awareness-precision-medicine-advancements-and-expanding-targeted-therapy-pipeline-through-2034/</loc>
		<lastmod>2026-08-07T10:28:27+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaglobenewswire.com/hydrocephalus-market-poised-for-growth-as-device-innovation-and-disease-awareness-advance-through-2034-delveinsight/</loc>
		<lastmod>2026-08-07T06:55:52+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaglobenewswire.com/exosomes-pipeline-2026-emerging-therapies-key-companies-and-clinical-trial-insights/</loc>
		<lastmod>2026-08-06T12:27:54+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaglobenewswire.com/the-global-radiofrequency-ablation-devices-market-size-is-projected-to-grow-at-a-cagr-of-11-23-during-the-forecast-period-from-2026-to-2034-delveinsight/</loc>
		<lastmod>2026-08-06T06:20:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaglobenewswire.com/membranous-nephropathy-market-set-for-strong-growth-driven-by-emerging-targeted-therapies-and-expanding-pipeline-through-2036/</loc>
		<lastmod>2026-08-05T11:07:53+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaglobenewswire.com/neuroendocrine-prostate-cancer-market-set-to-grow-through-2034-as-dll3-targeted-bispecifics-radioligand-therapies-and-bxcl701-advance-through-the-pipeline/</loc>
		<lastmod>2026-08-05T05:35:14+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaglobenewswire.com/the-global-transcatheter-embolization-and-occlusion-devices-market-size-is-projected-to-grow-at-a-cagr-of-9-3-during-the-forecast-period-from-2026-to-2034-delveinsight/</loc>
		<lastmod>2026-08-05T04:48:52+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaglobenewswire.com/hiatal-hernia-market-to-expand-through-2034-with-rising-minimally-invasive-treatment-adoption/</loc>
		<lastmod>2026-08-04T07:50:20+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaglobenewswire.com/pneumococcal-infections-pipeline-set-to-expand-as-next-generation-higher-valent-conjugate-vaccines-advance-through-late-stage-development/</loc>
		<lastmod>2026-08-04T06:16:45+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaglobenewswire.com/the-global-cataract-surgery-devices-market-size-is-projected-to-grow-at-a-cagr-of-5-07-during-the-forecast-period-from-2026-to-2034-delveinsight/</loc>
		<lastmod>2026-08-04T04:33:43+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaglobenewswire.com/treatment-resistant-hypertension-market-set-to-witness-significant-growth-driven-by-rising-prevalence-pipeline-advancements-and-expanding-therapeutic-options-through-2034/</loc>
		<lastmod>2026-08-03T10:33:38+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaglobenewswire.com/hypertrophic-cardiomyopathy-market-set-to-expand-through-2036-as-cardiac-myosin-inhibitor-class-reshapes-the-treatment-landscape/</loc>
		<lastmod>2026-08-03T06:23:55+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaglobenewswire.com/optical-coherence-tomography-devices-market-size-is-estimated-to-grow-at-a-cagr-of-8-57-by-2030-estimates-delveinsight/</loc>
		<lastmod>2026-08-03T05:15:07+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaglobenewswire.com/osteosarcoma-therapeutics-market-positioned-for-significant-commercial-growth-by-2034-estimates-delveinsight/</loc>
		<lastmod>2026-07-31T07:14:24+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaglobenewswire.com/lupus-nephritis-market-set-to-witness-significant-growth-driven-by-rising-prevalence-targeted-therapies-and-expanding-pipeline-through-2036/</loc>
		<lastmod>2026-07-31T05:29:58+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaglobenewswire.com/intracerebral-hemorrhage-market-set-to-witness-notable-change-driven-by-evolving-treatment-practices-epidemiological-trends-and-emerging-therapies-through-2032/</loc>
		<lastmod>2026-07-30T09:55:59+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaglobenewswire.com/non-muscle-invasive-bladder-cancer-pipeline-insight-2026/</loc>
		<lastmod>2026-07-30T05:35:54+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaglobenewswire.com/sensorineural-hearing-loss-market-set-to-witness-significant-growth-driven-by-rising-prevalence-technological-advancements-and-expanding-therapeutic-options-through-2034/</loc>
		<lastmod>2026-07-29T07:09:21+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaglobenewswire.com/myasthenia-gravis-market-size-was-usd-6-billion-in-the-7mm-in-2025-and-is-expected-to-grow-at-a-significant-cagr-through-2036-estimates-delveinsight/</loc>
		<lastmod>2026-07-29T05:17:53+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaglobenewswire.com/mismatch-repair-deficiency-dmmr-market-set-to-witness-continued-growth-driven-by-rising-testing-uptake-checkpoint-inhibitor-expansion-and-a-robust-emerging-pipeline-through-2034/</loc>
		<lastmod>2026-07-28T09:39:21+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaglobenewswire.com/mismatch-repair-deficiency-market-comprehensive-epidemiology-analysis-and-forecast-through-2034/</loc>
		<lastmod>2026-07-28T06:57:20+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaglobenewswire.com/infectious-disease-diagnostics-market-forecast-signals-robust-industry-growth-through-2034/</loc>
		<lastmod>2026-07-28T05:15:33+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaglobenewswire.com/post-polycythemia-vera-myelofibrosis-market-set-to-witness-significant-growth-through-2032-amid-rising-prevalence-and-evolving-treatment-landscape/</loc>
		<lastmod>2026-07-27T10:19:41+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaglobenewswire.com/the-ablation-devices-market-size-is-estimated-to-grow-at-a-cagr-of-8-38-by-2034-estimates-delveinsight/</loc>
		<lastmod>2026-07-27T08:07:11+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaglobenewswire.com/pertussis-pipeline-outlook-report-2026-10-key-companies-and-innovative-therapies-advancing-the-fight-against-whooping-cough/</loc>
		<lastmod>2026-07-24T13:51:08+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaglobenewswire.com/car-t-cell-therapy-market-outlook-pipeline-advances-growth-trends-and-forecast-through-2034/</loc>
		<lastmod>2026-07-24T07:18:45+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaglobenewswire.com/cervix-lesion-market-set-to-witness-notable-developments-backed-by-epidemiological-trends-evolving-treatment-practices-and-emerging-pipeline-therapies-through-2032/</loc>
		<lastmod>2026-07-23T07:09:18+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaglobenewswire.com/dna-microarray-market-strong-growth-forecast-through-2034-delveinsight/</loc>
		<lastmod>2026-07-23T07:04:05+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaglobenewswire.com/facioscapulohumeral-muscular-dystrophy-clinical-trial-pipeline-accelerates-as-10-pharma-companies-rigorously-develop-drugs-for-market-entry/</loc>
		<lastmod>2026-07-23T05:54:05+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaglobenewswire.com/amyloidosis-market-set-to-witness-significant-transformation-driven-by-epidemiological-trends-emerging-therapies-and-evolving-treatment-landscape-through-2036/</loc>
		<lastmod>2026-07-22T07:00:20+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaglobenewswire.com/postpartum-depression-pipeline-2026-key-drug-candidates-clinical-trials-and-market-insights/</loc>
		<lastmod>2026-07-22T06:21:50+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaglobenewswire.com/parkinsons-disease-levodopa-induced-dyskinesia-market-set-to-witness-significant-growth-driven-by-rising-prevalence-pipeline-advancements-and-expanding-therapeutic-options-through-2034/</loc>
		<lastmod>2026-07-21T09:06:37+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaglobenewswire.com/inclusion-body-myositis-therapeutics-market-size-in-the-7mm-is-anticipated-to-increase-at-a-significant-cagr-by-2034-estimates-delveinsight-2/</loc>
		<lastmod>2026-07-21T06:39:15+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaglobenewswire.com/spinocerebellar-ataxias-pipeline-gains-momentum-with-10-emerging-therapies-across-clinical-development-driven-by-advances-in-gene-silencing-and-regenerative-medicine/</loc>
		<lastmod>2026-07-21T04:55:39+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaglobenewswire.com/ovarian-cancer-market-set-to-witness-significant-growth-driven-by-rising-disease-burden-pipeline-advancements-and-expanding-targeted-therapies-through-2034/</loc>
		<lastmod>2026-07-20T10:33:56+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaglobenewswire.com/healthcare-analytics-market-market-insights-trends-and-forecast-2034/</loc>
		<lastmod>2026-07-20T06:41:19+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaglobenewswire.com/alk-positive-non-small-cell-lung-cancer-pipeline-landscape-reveals-promising-therapeutic-advances/</loc>
		<lastmod>2026-07-20T06:32:55+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaglobenewswire.com/shingles-pipeline-insight-2026-comprehensive-analysis-of-emerging-therapies-and-clinical-development/</loc>
		<lastmod>2026-07-17T10:54:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaglobenewswire.com/minimal-residual-disease-market-set-to-witness-significant-growth-driven-by-rising-cancer-incidence-technological-advancements-and-expanding-testing-adoption-through-2032/</loc>
		<lastmod>2026-07-17T09:48:06+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaglobenewswire.com/the-global-herbal-medicine-market-was-valued-at-usd-71445-63-million-in-2024-growing-at-a-cagr-of-10-18-to-reach-usd-154072-10-million-by-2032-estimates-delveinsight/</loc>
		<lastmod>2026-07-16T11:42:33+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaglobenewswire.com/liquid-biopsy-in-cancer-diagnostics-market-set-to-witness-significant-growth-driven-by-rising-cancer-burden-genomic-innovation-and-expanding-clinical-adoption-through-2034/</loc>
		<lastmod>2026-07-16T10:57:44+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaglobenewswire.com/nanomedicine-market-to-reach-usd-507-billion-by-2032-driven-by-targeted-drug-delivery-innovations-and-expanding-precision-medicine-applications/</loc>
		<lastmod>2026-07-15T09:37:57+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaglobenewswire.com/osteosarcoma-market-significant-growth-driven-by-innovation-and-emerging-therapies-delveinsight-2/</loc>
		<lastmod>2026-07-15T09:36:26+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaglobenewswire.com/chronic-myeloid-leukemia-pipeline-2026-clinical-trials-landscape-with-moa-and-roa-highlights-by-delveinsight/</loc>
		<lastmod>2026-07-15T08:02:42+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaglobenewswire.com/coronary-microvascular-dysfunction-market-set-to-witness-notable-growth-driven-by-rising-prevalence-diagnostic-advancements-and-emerging-treatment-approaches-through-2034/</loc>
		<lastmod>2026-07-14T12:11:43+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaglobenewswire.com/neurovascular-devices-market-size-is-estimated-to-grow-at-a-cagr-of-8-40-by-2034-estimates-delveinsight/</loc>
		<lastmod>2026-07-14T10:58:54+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaglobenewswire.com/pde4b-inhibitor-market-set-to-witness-significant-growth-driven-by-rising-chronic-disease-burden-pipeline-advancements-and-multi-indication-potential-through-2034/</loc>
		<lastmod>2026-07-13T19:24:40+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaglobenewswire.com/neurofibromatosis-market-in-the-7mm-is-expected-to-witness-a-major-change-during-the-study-period-2019-2032-estimates-delveinsight/</loc>
		<lastmod>2026-07-13T13:18:38+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaglobenewswire.com/vrdn-001-market-set-to-witness-strong-growth-driven-by-phase-iii-success-best-in-class-positioning-and-expanding-thyroid-eye-disease-opportunity-through-2034/</loc>
		<lastmod>2026-07-10T13:14:23+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaglobenewswire.com/cannabinoid-pipeline-2026-clinical-trials-landscape-with-moa-and-roa-highlights-by-delveinsight/</loc>
		<lastmod>2026-07-10T13:07:54+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaglobenewswire.com/pulmonary-arterial-hypertension-pipeline-advances-as-55-pharma-companies-rigorously-develop-drugs-for-market-entry-delveinsight/</loc>
		<lastmod>2026-07-10T11:24:01+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaglobenewswire.com/functional-dyspepsia-market-size-in-the-7mm-is-projected-to-grow-at-a-significant-cagr-by-2034-estimates-delveinsight/</loc>
		<lastmod>2026-07-09T11:28:29+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaglobenewswire.com/tepezza-market-set-to-witness-continued-growth-driven-by-strong-commercial-uptake-lifecycle-expansion-and-rising-demand-in-thyroid-eye-disease-through-2034/</loc>
		<lastmod>2026-07-09T09:08:01+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaglobenewswire.com/condom-market-statistics-expected-to-experience-major-growth-by-2030-according-to-delveinsight-2/</loc>
		<lastmod>2026-07-08T10:45:49+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaglobenewswire.com/tracheostomy-products-market-to-reach-usd-310-74-million-by-2032-driven-by-rising-copd-burden-and-mechanical-ventilation-demand/</loc>
		<lastmod>2026-07-08T07:32:57+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaglobenewswire.com/advanced-ovarian-cancer-pipeline-therapeutics-is-anticipated-to-witness-significant-growth-by-2026-estimates-delveinsight/</loc>
		<lastmod>2026-07-08T05:50:03+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaglobenewswire.com/antisense-oligonucleotide-therapeutics-pipeline-insight-2026-comprehensive-analysis-of-150-companies-and-200-emerging-drugs-transforming-rna-targeted-treatment/</loc>
		<lastmod>2026-07-07T16:48:53+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaglobenewswire.com/acromegaly-pipeline-therapeutics-is-anticipated-to-witness-significant-growth-by-2026-estimates-delveinsight/</loc>
		<lastmod>2026-07-07T07:10:24+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaglobenewswire.com/leptomeningeal-metastases-market-size-was-usd-1-7-billion-in-2024-with-strong-growth-expected-by-2034/</loc>
		<lastmod>2026-07-06T18:01:06+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaglobenewswire.com/lymphocytopenia-market-insights-epidemiology-and-market-forecast-2034/</loc>
		<lastmod>2026-07-06T07:53:28+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaglobenewswire.com/multiple-system-atrophy-therapeutics-market-size-in-the-7mm-is-anticipated-to-increase-at-a-significant-cagr-by-2036-estimates-delveinsight/</loc>
		<lastmod>2026-07-03T10:44:20+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaglobenewswire.com/crispr-therapies-pipeline-insight-2026-comprehensive-analysis-of-25-companies-and-30-emerging-drugs-transforming-genome-editing-treatment/</loc>
		<lastmod>2026-07-02T13:12:26+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaglobenewswire.com/hemophilia-pipeline-shows-potential-with-active-contributions-from-50-key-companies-delveinsight/</loc>
		<lastmod>2026-07-02T08:01:25+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaglobenewswire.com/condom-market-statistics-expected-to-experience-major-growth-by-2030-according-to-delveinsight/</loc>
		<lastmod>2026-07-02T07:56:15+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaglobenewswire.com/comprehensive-lyme-disease-market-analysis-covering-epidemiology-pipeline-forecast-emerging-therapies-and-growth-trends/</loc>
		<lastmod>2026-07-01T13:05:28+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaglobenewswire.com/polycystic-ovarian-syndrome-market-is-expected-to-grow-significantly-through-2034-driven-by-rising-prevalence-improved-diagnostics-and-expanding-pipeline-estimates-delveinsight/</loc>
		<lastmod>2026-07-01T12:20:58+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaglobenewswire.com/fabry-disease-therapeutics-market-size-in-the-7mm-is-anticipated-to-increase-at-a-significant-cagr-by-2036-estimates-delveinsight/</loc>
		<lastmod>2026-06-30T10:35:21+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaglobenewswire.com/atrial-fibrillation-market-set-to-witness-significant-growth-driven-by-rising-prevalence-technological-advancements-and-expanding-therapeutic-options-through-2034/</loc>
		<lastmod>2026-06-30T10:28:43+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaglobenewswire.com/japan-healthcare-outlook-report-2025-by-delveinsight/</loc>
		<lastmod>2026-06-29T14:39:16+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaglobenewswire.com/peanut-allergy-market-set-to-witness-significant-growth-driven-by-rising-prevalence-pipeline-advancements-and-expanding-treatment-options-through-2034/</loc>
		<lastmod>2026-06-29T12:09:33+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaglobenewswire.com/audiology-devices-market-size-is-estimated-to-grow-at-a-cagr-of-5-63-by-2032-estimates-delveinsight/</loc>
		<lastmod>2026-06-27T08:46:54+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaglobenewswire.com/bipolar-disorder-manic-depression-market-set-to-witness-significant-growth-driven-by-rising-prevalence-pipeline-advancements-and-expanding-therapeutic-options-through-2030/</loc>
		<lastmod>2026-06-26T07:40:06+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaglobenewswire.com/basal-cell-neoplasms-market-set-to-witness-significant-growth-driven-by-rising-prevalence-pipeline-advancements-and-expanding-therapeutic-options-through-2034/</loc>
		<lastmod>2026-06-25T12:14:44+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaglobenewswire.com/recurrent-pericarditis-market-shows-strong-growth-potential-with-emerging-targeted-therapies-by-2032-delveinsight/</loc>
		<lastmod>2026-06-25T10:47:36+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaglobenewswire.com/pericarditis-market-set-to-witness-significant-growth-driven-by-rising-disease-awareness-advancing-pipeline-therapies-and-expanding-treatment-options-through-2032/</loc>
		<lastmod>2026-06-24T10:20:22+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaglobenewswire.com/progressive-multifocal-leukoencephalopathy-pipeline-insights-accelerates-as-3-pharma-companies-rigorously-develop-drugs-for-market-entry-delveinsight/</loc>
		<lastmod>2026-06-24T06:59:27+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaglobenewswire.com/wearable-medical-devices-market-insights-competitive-landscape-and-market-forecast-2032/</loc>
		<lastmod>2026-06-23T17:02:43+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaglobenewswire.com/nuclear-magnetic-resonance-nmr-spectroscopy-market-to-grow-at-a-cagr-of-5-21-through-2030-driven-by-expanding-drug-discovery-applications-technological-advancements-and-rising-clinical-research-a/</loc>
		<lastmod>2026-06-23T09:26:27+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaglobenewswire.com/hearing-aid-devices-market-size-is-estimated-to-grow-at-a-cagr-of-5-45-by-2030-estimates-delveinsight/</loc>
		<lastmod>2026-06-23T07:26:19+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaglobenewswire.com/neurology-devices-market-size-is-estimated-to-grow-at-a-cagr-of-7-46-by-2030-estimates-delveinsight/</loc>
		<lastmod>2026-06-19T09:58:35+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaglobenewswire.com/patient-monitoring-devices-market-size-is-estimated-to-grow-at-a-cagr-of-10-01-by-2032-estimates-delveinsight/</loc>
		<lastmod>2026-06-18T12:15:48+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaglobenewswire.com/neuroprotection-devices-market-insights-competitive-landscape-and-market-forecast-2032/</loc>
		<lastmod>2026-06-18T11:18:27+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaglobenewswire.com/brain-imaging-devices-market-set-for-transformative-growth-driven-by-pipeline-innovation-rising-diagnosis-rates-and-expanding-therapeutic-landscape-through-2032/</loc>
		<lastmod>2026-06-18T11:07:35+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaglobenewswire.com/the-global-next-generation-sequencing-market-size-is-estimated-to-grow-at-a-cagr-of-18-96-by-2030-estimates-delveinsight/</loc>
		<lastmod>2026-06-17T12:22:05+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaglobenewswire.com/motor-neuron-disease-pipeline-2026-emerging-gene-therapies-stem-cell-innovations-and-precision-medicine-approaches-transform-the-treatment-landscape/</loc>
		<lastmod>2026-06-17T11:28:34+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaglobenewswire.com/deep-brain-stimulation-devices-market-size-is-estimated-to-grow-at-a-cagr-of-10-40-by-2034-estimates-delveinsight/</loc>
		<lastmod>2026-06-16T11:04:14+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaglobenewswire.com/patient-monitoring-devices-market-set-to-witness-significant-growth-driven-by-rising-chronic-disease-burden-technological-advancements-and-expanding-monitoring-solutions-through-2032/</loc>
		<lastmod>2026-06-15T18:24:21+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaglobenewswire.com/the-surgical-sutures-market-size-is-estimated-to-grow-at-a-cagr-of-6-20-by-2032-estimates-delveinsight/</loc>
		<lastmod>2026-06-12T11:33:31+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaglobenewswire.com/thalassemia-market-set-to-witness-significant-growth-driven-by-rising-prevalence-pipeline-advancements-and-expanding-therapeutic-options-through-2034/</loc>
		<lastmod>2026-06-12T10:49:22+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaglobenewswire.com/laryngeal-cancer-market-is-projected-to-grow-at-a-significant-cagr-through-2034-estimates-delveinsight/</loc>
		<lastmod>2026-06-11T12:07:16+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaglobenewswire.com/presbyopia-clinical-trial-pipeline-gains-momentum-6-companies-lead-the-charge-in-pioneering-new-treatments/</loc>
		<lastmod>2026-06-11T10:18:26+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaglobenewswire.com/myelofibrosis-market-set-to-witness-significant-growth-driven-by-rising-prevalence-pipeline-advancements-and-expanding-therapeutic-options-through-2036/</loc>
		<lastmod>2026-06-11T09:56:44+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaglobenewswire.com/tyk2-inhibitor-market-size-in-the-7mm-is-projected-to-grow-at-a-significant-cagr-by-2034-according-to-delveinsight/</loc>
		<lastmod>2026-06-10T12:02:07+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaglobenewswire.com/pde4-inhibitors-market-size-in-the-7mm-is-projected-to-grow-at-a-significant-cagr-over-the-study-period-of-2020-2034-according-to-delveinsight/</loc>
		<lastmod>2026-06-10T11:26:47+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaglobenewswire.com/interleukin-23-inhibitors-market-size-in-the-7mm-is-projected-to-grow-at-a-significant-cagr-by-2034-according-to-delveinsight/</loc>
		<lastmod>2026-06-10T11:05:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaglobenewswire.com/the-epilepsy-market-size-across-the-7mm-was-valued-at-nearly-usd-9-billion-in-2023-and-is-expected-to-grow-at-a-cagr-of-7-during-2026-2036/</loc>
		<lastmod>2026-06-10T10:58:12+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaglobenewswire.com/chronic-gout-market-set-to-witness-significant-growth-driven-by-rising-prevalence-pipeline-advancements-and-expanding-therapeutic-options-through-2034/</loc>
		<lastmod>2026-06-10T10:24:37+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaglobenewswire.com/ductal-carcinoma-in-situ-therapeutics-market-size-in-the-7mm-is-projected-to-grow-at-a-significant-cagr-by-2034-according-to-delveinsight/</loc>
		<lastmod>2026-06-10T09:58:09+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaglobenewswire.com/the-global-infusion-pumps-market-was-valued-at-usd-13-80-billion-in-2024-growing-at-a-cagr-of-9-54-to-reach-usd-23-85-billion-by-2032-estimates-delveinsight/</loc>
		<lastmod>2026-06-09T10:41:54+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaglobenewswire.com/chronic-refractory-cough-market-hits-8-5b-in-2024/</loc>
		<lastmod>2026-06-09T10:20:12+00:00</lastmod>
		<image:image>
			<image:loc>https://www.pharmaglobenewswire.com/wp-content/uploads/2026/06/image-1.png</image:loc>
		</image:image>
	</url>
	<url>
		<loc>https://www.pharmaglobenewswire.com/bone-marrow-failure-market-set-for-transformative-growth-driven-by-pipeline-innovation-rising-diagnosis-rates-and-expanding-therapeutic-landscape-through-2034/</loc>
		<lastmod>2026-06-09T09:33:53+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaglobenewswire.com/4775-2/</loc>
		<lastmod>2026-06-08T10:13:29+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaglobenewswire.com/pharmaceuticals-market-set-to-reach-usd-2435-53-billion-by-2032-driven-by-rising-disease-burden-rd-innovation-and-expanding-biologic-therapies/</loc>
		<lastmod>2026-06-08T04:47:44+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaglobenewswire.com/gastroparesis-therapeutics-market-size-7mm-was-usd-150-million-in-the-us-in-2025-and-is-projected-to-grow-at-18-cagr-by-2036/</loc>
		<lastmod>2026-06-07T17:48:12+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaglobenewswire.com/mobile-clinics-market-insights-competitive-landscape-and-market-forecast-2032-growing-healthcare-access-gaps-strategic-collaborations-and-specialized-care-innovation-drive-market-expansion/</loc>
		<lastmod>2026-06-05T11:02:37+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaglobenewswire.com/total-knee-arthroplasty-market-insights-competitive-landscape-and-market-forecast-2032/</loc>
		<lastmod>2026-06-04T14:52:26+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaglobenewswire.com/hodgkins-lymphoma-market-insight-epidemiology-and-market-forecast-2036-advancing-immunotherapy-targeted-therapies-and-precision-medicine-drive-market-expansion/</loc>
		<lastmod>2026-06-04T10:53:03+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaglobenewswire.com/the-psoriasis-market-size-is-estimated-to-grow-at-a-cagr-of-1-70-by-2034-estimates-delveinsight/</loc>
		<lastmod>2026-06-03T04:54:33+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaglobenewswire.com/untreated-metastatic-or-unresectable-melanoma-pipeline-insight-2026-advancing-immunotherapy-targeted-therapies-and-novel-modalities-drive-a-robust-development-landscape/</loc>
		<lastmod>2026-06-03T04:42:43+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaglobenewswire.com/febrile-neutropenia-market-poised-for-steady-growth-as-biosimilars-reshape-competitive-landscape-through-2036-delveinsight/</loc>
		<lastmod>2026-06-02T11:33:47+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaglobenewswire.com/bioanalytical-testing-services-market-set-for-robust-growth-rising-chronic-disease-burden-advanced-analytical-technologies-and-expanding-rd-pipeline-drive-global-opportunities-through-2032/</loc>
		<lastmod>2026-06-02T05:16:33+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaglobenewswire.com/post-traumatic-stress-disorder-ptsd-market-poised-for-robust-growth-backed-by-a-strong-pipeline-and-rising-prevalence-through-2034-delveinsight/</loc>
		<lastmod>2026-06-01T12:16:53+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaglobenewswire.com/non-cystic-fibrosis-bronchiectasis-market-set-for-robust-growth-rising-prevalence-innovative-therapies-and-expanding-pipeline-drive-global-opportunities-through-2034/</loc>
		<lastmod>2026-06-01T04:55:30+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaglobenewswire.com/thyroid-gland-disorder-treatment-market-rising-prevalence-rd-breakthroughs-and-expanding-therapeutic-pipeline-drive-robust-global-growth-through-2032/</loc>
		<lastmod>2026-05-29T04:58:36+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaglobenewswire.com/pneumococcal-infections-pipeline-insight-2026-comprehensive-analysis-of-18-companies-and-20-emerging-drugs-transforming-infectious-disease-treatment/</loc>
		<lastmod>2026-05-28T11:32:14+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaglobenewswire.com/celiac-disease-market-size-7mm-is-projected-to-grow-at-a-significant-cagr-by-2034-driven-by-rising-diagnosis-rates-and-an-expanding-pharmacological-pipeline-estimates-delveinsight/</loc>
		<lastmod>2026-05-28T10:57:18+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaglobenewswire.com/facioscapulohumeral-muscular-dystrophy-market-unlocking-revolutionary-treatment-opportunities-through-emerging-gene-targeting-therapies-by-2036-delveinsight/</loc>
		<lastmod>2026-05-27T11:00:18+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaglobenewswire.com/big-data-in-healthcare-market-set-to-reach-usd-338-96-billion-by-2032-driven-by-chronic-disease-surge-and-technological-innovations/</loc>
		<lastmod>2026-05-27T09:12:41+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaglobenewswire.com/eosinophilic-esophagitis-therapeutics-market-size-7mm-was-usd-901-million-in-2025-and-is-projected-to-reach-usd-3543-million-growing-at-12-9-cagr-by-2036-estimates-delveinsight/</loc>
		<lastmod>2026-05-26T08:01:35+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaglobenewswire.com/merkel-cell-carcinoma-market-emerging-therapies-epidemiology-key-players-and-treatment-landscape-insights-through-2034/</loc>
		<lastmod>2026-05-26T05:59:06+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaglobenewswire.com/psoriatic-arthritis-therapeutics-market-size-7mm-projected-to-grow-at-significant-cagr-by-2034-estimates-delveinsight/</loc>
		<lastmod>2026-05-25T09:56:59+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaglobenewswire.com/wet-age-related-macular-degeneration-market-global-trends-epidemiology-emerging-therapies-and-growth-forecast-across-the-7mm-through-2036/</loc>
		<lastmod>2026-05-25T05:33:47+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaglobenewswire.com/inflammatory-bowel-disease-therapeutics-market-size-in-the-7mm-is-anticipated-to-increase-at-a-significant-cagr-by-2036-estimates-delveinsight/</loc>
		<lastmod>2026-05-22T09:57:26+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaglobenewswire.com/crohns-disease-market-set-for-significant-growth-rising-prevalence-biologic-innovations-and-emerging-therapies-drive-expansion-through-2034/</loc>
		<lastmod>2026-05-22T04:44:13+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaglobenewswire.com/infusion-pumps-market/</loc>
		<lastmod>2026-05-21T13:12:56+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaglobenewswire.com/alcohol-use-disorder-pipeline/</loc>
		<lastmod>2026-05-21T13:06:01+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaglobenewswire.com/atopic-dermatitis-pipeline/</loc>
		<lastmod>2026-05-21T12:58:41+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaglobenewswire.com/big-data-in-healthcare-market-expected-to-witness-robust-growth-by-2032-across-global-markets-delveinsight/</loc>
		<lastmod>2026-05-21T12:04:06+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaglobenewswire.com/exosomes-pipeline-insights-2026-emerging-therapies-clinical-advances-and-industry-leaders/</loc>
		<lastmod>2026-05-21T10:07:24+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaglobenewswire.com/pulmonary-arterial-hypertension-market-set-for-robust-growth-driven-by-innovative-therapies-expanding-pipeline-and-rising-global-disease-burden-through-2036/</loc>
		<lastmod>2026-05-21T04:50:33+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaglobenewswire.com/growth-hormone-deficiency-market-expansion-driven-by-rising-cases-advancing-therapies-and-increasing-treatment-adoption-across-seven-major-markets-forecast-2025-to-2034-with-market-size-rising-from/</loc>
		<lastmod>2026-05-20T09:49:49+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaglobenewswire.com/inclusion-body-myositis-therapeutics-market-size-in-the-7mm-is-anticipated-to-increase-at-a-significant-cagr-by-2034-estimates-delveinsight/</loc>
		<lastmod>2026-05-20T09:34:40+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaglobenewswire.com/huntingtons-disease-therapeutics-market-size-in-the-7mm-is-anticipated-to-increase-at-a-significant-cagr-of-14-by-2036-estimates-delveinsight/</loc>
		<lastmod>2026-05-19T10:30:38+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaglobenewswire.com/osteosarcoma-market-significant-growth-driven-by-innovation-and-emerging-therapies-delveinsight/</loc>
		<lastmod>2026-05-19T10:24:47+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaglobenewswire.com/revolutionary-advances-in-diffuse-large-b-cell-lymphoma-treatment-drive-unprecedented-market-growth-projected-to-reach-usd-16-56-billion-by-2034/</loc>
		<lastmod>2026-05-19T04:18:43+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaglobenewswire.com/uncontrolled-bleeding-pipeline-insight-2026/</loc>
		<lastmod>2026-05-18T12:55:49+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaglobenewswire.com/slamf7-inhibitors-market-expected-to-witness-significant-growth-by-2034-across-the-7mm-delveinsight/</loc>
		<lastmod>2026-05-18T10:12:16+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaglobenewswire.com/follicular-lymphoma-market-to-witness-remarkable-growth-key-therapies-epidemiological-trends-and-emerging-treatment-innovations-driving-the-global-landscape-through-2036/</loc>
		<lastmod>2026-05-18T04:46:25+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaglobenewswire.com/ox40-ligand-inhibitors-market-report-2034-emerging-therapies-competitive-landscape-and-forecast-analysis-across-7mm/</loc>
		<lastmod>2026-05-15T11:27:09+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaglobenewswire.com/netherton-syndrome-market-set-to-witness-significant-growth-through-2036-driven-by-emerging-targeted-therapies-and-rising-disease-awareness-2/</loc>
		<lastmod>2026-05-15T10:02:05+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaglobenewswire.com/malignant-pleural-effusion-market-set-to-surpass-usd-2-billion-globally-driven-by-rising-cancer-incidence-emerging-therapies-and-advancing-diagnostic-technologies-through-2034/</loc>
		<lastmod>2026-05-15T05:44:05+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaglobenewswire.com/netherton-syndrome-market-set-to-witness-significant-growth-through-2036-driven-by-emerging-targeted-therapies-and-rising-disease-awareness/</loc>
		<lastmod>2026-05-14T12:44:19+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaglobenewswire.com/acute-myeloid-leukemia-clinical-trial-pipeline-gains-momentum-with-150-therapies-in-development-across-global-markets-delveinsight/</loc>
		<lastmod>2026-05-14T11:41:30+00:00</lastmod>
	</url>
</urlset>
<!-- XML Sitemap generated by Rank Math SEO Plugin (c) Rank Math - rankmath.com -->